Cardinal Health Investigator for EPCIS workshop series will take place monthly on the third Wednesday of each month. During the workshop, Cardinal Health and LSPEDIA will provide an overview of EPCIS and the streamlined process to ramp up EPCIS testing. This webinar will address the EPCIS data exchange and harmonization of EPCIS exceptions workflow towards meeting the November 2023 Drug Supply Chain Security Act (DSCSA) requirement.
Customer Training: Everything New in OneScan 5.0 We are excited to announce the release of OneScan 5.0 going live at the end of October 2021! LSPediA has been planning an…
HDA EPCIS Survey Report LSPediA’s next Customer Advisory Board Meeting on Wednesday, October 13th, 2021 at 3 PM EDT. We’ll provide latest news and information about product releases, support, and industry activities. Guest Speaker…
Ensuring food safety and traceability is one of the biggest issues facing the industry right now. LSPediA’s OneScan solution is the tech solution for the problem.
LSPediA provides SaaS solutions to the pharmaceutical industry. Manufacturers, wholesale distributors, dispensers, and healthcare providers use LSPediA’s solutions to move, track, and verify their serialized products. Furthermore, LSPediA resolves DSCSA data issues and…
Israel is familiar with the challenges that an unfit DSCSA solution can bring to his clients. He has seen the frustration his customers. In 2020, his customers came to him…
Drug Supply Chain Security Act (DSCSA) creates an array of new changes for how business is conducted in the pharmaceutical supply chain. However, this is not a new phenomenon as…
When I last provided a comprehensive Drug Supply Chain Security Act (DSCSA) update two years ago, verification was a major theme required of 2019 Saleable Returns for wholesalers. That requirement…
1 DSCSA and Real-World Challenges: Supply Chain Disruptions The challenging task of distributing generic pharmaceuticals to a huge network of hospitals, pharmacies, prisons and more in 48 states in the…
West Bloomfield, MI- July 9, 2020 LSPediA today announced the release of OneScan 4.0, LSPediA’s comprehensive DSCSA solution. This is the 4th product upgrade since its go-live date of November…
To help pharmaceutical manufacturers to comply with DSCSA Saleable Returns requirements and learn how Smith Drug Company resolves saleable returns verification issues (specifically the negative verification responses), LSPediA now has…
Join this supplier webcast from Smith Drug Company about the recent supplier communication letter for resolving saleable returns verification issues, specifically the negative verification responses, to meet the DSCSA Saleable…
